KPTN

KPTN (kaptin) is an actin-binding protein and core subunit of the KICSTOR complex that functions as a negative regulator of mTORC1 signaling by facilitating recruitment of the GATOR1 complex to the lysosomal surface. KPTN binds F-actin in an ATP-sensitive manner and localizes to sites of active actin polymerization, including stereocilia tips and lamellipodia; disease-causing mutations abolish this actin association and disrupt neuromorphogenesis (PMID:10099934, PMID:24239382). KPTN's regulatory function within KICSTOR is modulated by non-degradative ubiquitination: FBXO2 promotes K48/K63-linked polyubiquitination at K49, K67, K262, and K265, disrupting KPTN–ITFG2/SZT2 interactions and impairing GATOR1 lysosomal recruitment, while OTUD3 reverses this modification to restore mTORC1 suppression (PMID:41401028, PMID:38288086). Loss-of-function mutations in KPTN cause a neurodevelopmental disorder characterized by macrocephaly, seizures, mTORC1 hyperactivation, increased cell size, and white matter heterotopic neurons, phenotypes that are rescued by rapamycin (PMID:24239382, PMID:37437211, PMID:41696790).

1. 1999 Medium

   The initial molecular identity of KPTN was established as an actin-binding protein with ATP-sensitive F-actin association, placing it at dynamic actin structures including stereocilia tips and lamellipodia.

   Evidence F-actin affinity chromatography and immunofluorescence in platelets, fibroblasts, and inner ear hair cells

   PMID:10099934

   Open questions at the time

   • Single lab; biochemical binding parameters (Kd, stoichiometry) not determined
   • Functional consequence of actin binding not tested by loss-of-function
   • Mechanism of ATP-dependent dissociation unresolved
2. 2000 Medium

   Precise sub-stereociliary localization beyond barbed ends strengthened the model that KPTN acts at sites of actin monomer addition, and its chromosomal locus was mapped to 19q13.4.

   Evidence Double-label immunofluorescence and FISH/radiation hybrid mapping

   PMID:11409409

   Open questions at the time

   • No direct demonstration that KPTN promotes or caps actin polymerization
   • No loss-of-function data in stereocilia
3. 2013 High

   Establishing KPTN as a disease gene, loss-of-function mutations were shown to cause macrocephaly, neurodevelopmental delay, and seizures, and the pathogenic mutations abolished KPTN's association with actin in neurons, linking actin binding to neuromorphogenesis.

   Evidence Whole-exome sequencing in multiple families, GFP-tagged wild-type and mutant KPTN immunofluorescence in primary neurons

   PMID:24239382

   Open questions at the time

   • Mechanism connecting loss of actin binding to macrocephaly unknown
   • mTOR pathway involvement not yet suspected
   • Animal model not yet generated
4. 2023 High

   A transformative shift in understanding occurred when KPTN was recognized as a KICSTOR subunit: Kptn knockout mice and human iPSC models showed mTORC1 hyperactivation that was correctable by rapamycin, reframing KPTN's primary disease-relevant function from cytoskeletal to mTOR signaling.

   Evidence Kptn−/− mouse, iPSC-derived models, Western blot of mTOR pathway, rapamycin rescue

   PMID:37437211

   Open questions at the time

   • How KPTN within KICSTOR mechanistically recruits GATOR1 not resolved
   • Relative contributions of actin-binding vs. mTOR-regulatory roles to pathology unclear
   • Post-translational regulation of KPTN not yet explored
5. 2024 High

   The discovery that OTUD3 deubiquitinates KPTN at K49 revealed that non-degradative ubiquitination is a regulatory switch controlling KPTN function: OTUD3-mediated deubiquitination promotes GATOR1 lysosomal localization and mTORC1 suppression.

   Evidence In vivo ubiquitination assay with K49 site mapping, co-IP, CRISPR KO, NMR domain analysis

   PMID:38288086

   Open questions at the time

   • E3 ligase responsible for K49 ubiquitination not yet identified in this study
   • Physiological stimuli triggering ubiquitination/deubiquitination cycles unknown
   • In vivo relevance of OTUD3–KPTN axis not tested
6. 2025 High

   FBXO2 was identified as the E3 ligase that ubiquitinates KPTN at four lysines (K49, K67, K262, K265) with K48/K63 linkages, and this modification selectively disrupts KPTN interactions with ITFG2 and SZT2 while enhancing C12orf66 binding, thereby mechanistically explaining how ubiquitination impairs GATOR1 lysosomal recruitment.

   Evidence Co-IP, linkage-specific ubiquitination assays, site-directed mutagenesis, GATOR1 recruitment assays

   PMID:41401028

   Open questions at the time

   • Signals activating FBXO2-mediated KPTN ubiquitination (e.g., amino acid sensing) not determined
   • Structural basis for how ubiquitination selectively remodels KICSTOR subunit interactions unknown
   • Interplay between FBXO2 and OTUD3 in dynamic regulation not characterized
7. 2026 High

   Focal Kptn knockout in developing cortex via in utero electroporation demonstrated that KPTN loss causes white matter heterotopic neurons, directly establishing KPTN as a regulator of cortical neuron positioning during development through mTOR-dependent mechanisms.

   Evidence CRISPR/Cas9 in vitro and in vivo KO, rapamycin rescue, in utero electroporation, histology

   PMID:41696790

   Open questions at the time

   • Whether heterotopia results from migration defect vs. aberrant proliferation not distinguished
   • Cell-type specificity of KPTN requirement in cortical development not resolved
   • Whether actin-binding function contributes to the migration phenotype untested

• The relative contributions of KPTN's actin-binding and KICSTOR/mTOR-regulatory functions remain unresolved, as does the structural basis of KPTN within the KICSTOR complex and the upstream signals that dynamically control its ubiquitination state.
• No separation-of-function mutants distinguishing actin-binding from KICSTOR roles
• No high-resolution structure of KPTN or KICSTOR
• Upstream nutrient/stress signals regulating FBXO2–OTUD3 balance on KPTN unknown